Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

Marc De Hert1, Johan Detraux, Ruud van Winkel

  • 1University Psychiatric Center, Catholic University Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium. marc.de.hert@ uc-kortenberg.be

Insights

Antipsychotic medications increase cardiovascular and metabolic risks, including type 2 diabetes. This review details these risks in adults and children, highlighting monitoring needs.

Area of Science:

  • Pharmacology
  • Cardiology
  • Endocrinology

Background:

  • Antipsychotic medications are linked to cardiovascular and metabolic issues like obesity, hyperglycemia, and dyslipidemia.
  • These adverse effects increase the risk of type 2 diabetes mellitus and cardiovascular disease.
  • Controversy exists regarding specific drug contributions and mechanisms, including QT interval prolongation.

Purpose of the Study:

  • To review the metabolic and cardiovascular risks associated with antipsychotic medications in adults and children.
  • To define healthcare disparities in monitoring these risks.
  • To provide recommendations for screening and monitoring patients on antipsychotic agents.

Main Methods:

  • Literature review of antipsychotic medications' cardiovascular and metabolic risks.
  • Analysis of pharmacological mechanisms and receptor-binding affinities.
  • Examination of healthcare disparities and monitoring practices.

Main Results:

  • Antipsychotic agents can cause glucose and lipid metabolism abnormalities through obesity-related and unrelated mechanisms.
  • Despite guidelines, many patients on antipsychotics are not screened for key metabolic and cardiac risk factors.
  • Increased use in pediatric populations raises concerns due to orexigenic effects.

Conclusions:

  • Antipsychotic medications pose significant metabolic and cardiovascular risks requiring careful management.
  • There are disparities in healthcare for monitoring these risks, particularly in vulnerable pediatric patients.
  • Enhanced screening and monitoring protocols are essential for patients taking antipsychotic medications.

Related Concept Videos

Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...